{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05571397",
            "orgStudyIdInfo": {
                "id": "2021H0407"
            },
            "secondaryIdInfos": [
                {
                    "id": "G220050",
                    "type": "OTHER",
                    "domain": "FDA"
                }
            ],
            "organization": {
                "fullName": "Ohio State University",
                "class": "OTHER"
            },
            "briefTitle": "Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes",
            "officialTitle": "Expanding Use of Continuous Glucose Monitoring Beyond COVID in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes",
            "acronym": "CGM",
            "therapeuticArea": [
                "Other"
            ],
            "study": "expanding-use-of-cgm-in-critical-care-impact-on-nurse-work-patterns-and-patient-outcomes"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-15",
            "studyFirstSubmitQcDate": "2022-10-04",
            "studyFirstPostDateStruct": {
                "date": "2022-10-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ohio State University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (\\>250mg/dl) in the critical care hospital environments.",
            "detailedDescription": "This study analyzes the feasibility of inpatient real time CGM implementation through the use of a CGM + POC protocol as routine care for glycemic monitoring among patients on IV insulin or those with hyperglycemia (\\>250mg/dl). The investigators will examine the effects on medical intensive care (MICU) patient's (N=100) glycemic control compared to matched historical control patients (N=100) from the MICU who received fingerstick POC."
        },
        "conditionsModule": {
            "conditions": [
                "Hyperglycemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "CGM will be used by 100 MICU patients with glycemic control comparison with matched 100 MICU historical controls",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dexcom CGM",
                    "type": "EXPERIMENTAL",
                    "description": "Dexcom G6",
                    "interventionNames": [
                        "Device: Dexcom G6"
                    ]
                },
                {
                    "label": "Historical Controls",
                    "type": "NO_INTERVENTION",
                    "description": "Matched historical controls"
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Dexcom G6",
                    "description": "Continuous Glucose Monitor",
                    "armGroupLabels": [
                        "Dexcom CGM"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Time in Range",
                    "description": "Percent glucose in ranges: 100-180 mg/dl, 70-180mg/dl, 140-180mg/d",
                    "timeFrame": "Daily during MICU admission; MICU length of stay to be determined by patient medical needs"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Time in hypoglycemia",
                    "description": "Percent glucose \\<70mg/dl and \\<55mg/dl",
                    "timeFrame": "Daily during MICU admission; MICU length of stay to be determined by patient medical needs"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* adults \\>18 years old,\n* admitted to Ohio State University Wexner Medical Center MICU and\n* have hyperglycemia (glucose \\>250mg/dl) or are currently on IV insulin.\n\nExclusion Criteria:\n\n* Current COVID-19 infection,\n* Refractory shock (Levophed dose \\>0.5 mcg/kg/min or equivalent)\n* Actively being treated for diabetic ketoacidosis (DKA)\n* Actively being treated for hyperosmolar non-ketoacidosis (HONK)\n* Pitting edema, anasarca, blue or purple discoloration to left upper extremity\n* Treated with high dose acetaminophen (\\>1 gram Q6 hours)\n* Treated with hydroxyurea\n* Are pregnant, patients\n* Using home insulin pump therapy during hospitalization, or\n* Reside in a corrections institution.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "EILEEN FAULDS, PhD",
                    "role": "CONTACT",
                    "phone": "4199890730",
                    "email": "eileen.faulds@osumc.edu"
                },
                {
                    "name": "Sandra Solove",
                    "role": "CONTACT",
                    "email": "solove.3@osu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "EILEEN FAULDS, PhD",
                    "affiliation": "Ohio State University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Ohio State University",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "EILEEN Faulds, PhD",
                            "role": "CONTACT",
                            "phone": "419-989-0730",
                            "email": "eileen.faulds@osumc.edu"
                        },
                        {
                            "name": "Sandra Solove",
                            "role": "CONTACT",
                            "email": "solove.3@osu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "Prot_SAP",
                    "hasProtocol": true,
                    "hasSap": true,
                    "hasIcf": false,
                    "label": "Study Protocol and Statistical Analysis Plan",
                    "date": "2022-04-26",
                    "uploadDate": "2022-10-04T10:23",
                    "filename": "Prot_SAP_000.pdf",
                    "size": 405495
                },
                {
                    "typeAbbrev": "ICF",
                    "hasProtocol": false,
                    "hasSap": false,
                    "hasIcf": true,
                    "label": "Informed Consent Form",
                    "date": "2021-11-05",
                    "uploadDate": "2022-09-21T16:35",
                    "filename": "ICF_001.pdf",
                    "size": 235292
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006943",
                    "term": "Hyperglycemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9994",
                    "name": "Hyperglycemia",
                    "asFound": "Hyperglycemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}